Geneva Capital Management LLC lowered its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 4.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 170,425 shares of the biotechnology company's stock after selling 8,621 shares during the quarter. Geneva Capital Management LLC owned 0.23% of Axon Enterprise worth $68,102,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in Axon Enterprise by 2.7% during the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company's stock worth $2,547,878,000 after buying an additional 212,401 shares during the last quarter. 1832 Asset Management L.P. increased its stake in shares of Axon Enterprise by 44.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company's stock worth $110,546,000 after purchasing an additional 114,800 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of Axon Enterprise by 13.9% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company's stock worth $108,496,000 after purchasing an additional 45,049 shares during the period. Thrivent Financial for Lutherans lifted its stake in Axon Enterprise by 1.6% in the second quarter. Thrivent Financial for Lutherans now owns 270,430 shares of the biotechnology company's stock valued at $79,571,000 after purchasing an additional 4,365 shares during the last quarter. Finally, Federated Hermes Inc. grew its holdings in Axon Enterprise by 14.5% during the second quarter. Federated Hermes Inc. now owns 234,185 shares of the biotechnology company's stock valued at $68,907,000 after purchasing an additional 29,680 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.
Axon Enterprise Price Performance
Axon Enterprise stock traded up $13.66 during mid-day trading on Wednesday, hitting $608.84. 446,746 shares of the company traded hands, compared to its average volume of 547,632. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a one year low of $220.51 and a one year high of $624.84. The stock has a market cap of $46.42 billion, a price-to-earnings ratio of 158.00, a price-to-earnings-growth ratio of 14.95 and a beta of 0.94. The stock has a fifty day moving average price of $423.98 and a 200-day moving average price of $351.79.
Insider Transactions at Axon Enterprise
In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of Axon Enterprise stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now owns 3,015,366 shares of the company's stock, valued at $1,121,052,771.48. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, CEO Patrick W. Smith sold 80,300 shares of the company's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the sale, the chief executive officer now owns 3,015,366 shares of the company's stock, valued at approximately $1,121,052,771.48. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick W. Smith sold 70,000 shares of Axon Enterprise stock in a transaction on Monday, August 26th. The stock was sold at an average price of $362.21, for a total transaction of $25,354,700.00. Following the completion of the transaction, the chief executive officer now owns 2,945,366 shares in the company, valued at approximately $1,066,841,018.86. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 369,172 shares of company stock valued at $136,270,842. Insiders own 6.10% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on AXON. Northland Securities upped their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a research report on Monday. Barclays upped their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a report on Wednesday, August 7th. Needham & Company LLC boosted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research report on Friday, November 8th. Jefferies Financial Group assumed coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a "buy" rating and a $385.00 price objective for the company. Finally, Robert W. Baird boosted their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an "outperform" rating in a report on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $427.83.
View Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report